• Services
    Applications Artificial & Augmented Intelligence Business Process Business Solutions Cloud
    Consulting Cybersecurity Data & Analytics Design & Experience Digital Marketing & Interaction
    Engineering Infrastructure Sustainability Talent Cloud
  • Industries
    Aerospace & Defense Automotive Banking Capital Markets Communications Consumer Electronics Consumer Packaged Goods
    Education Engineering Construction & Operations Healthcare Industrial & Process Manufacturing Insurance Life Sciences & Pharma
    Media & Info Services Medical Devices Natural Resources Network & Edge Providers Oil & Gas Platforms & Software Products Professional Services
    Public Sector Retail Semiconductors Transportation & Services Utilities
  • Insights
    Featured Insights From our CEO Business Strategy Digital Transformation Sustainability Technology Trends
  • About Wipro
    About Us Analyst Speak Awards and Recognitions Events Inclusion and Diversity Investors
    Lab45 Leadership Locations News Partner Ecosystem Sustainability
    The Story of Wipro Privacy at Wipro Supplier Diversity Wipro Ventures
  • Careers
  • Contact Us
Locations

America

country brazil Brazil En Po

country canada Canada

country latam Latam

country maxicoMexico En Sp

country usa United States

Europe En De

country benelux Benelux

country dach Germany & Austria En De

country nordic Nordic

country france Southern Europe En Fr

country switzerland Switzerland En De

United Kingdom & Ireland

Asia Pacific

countryAsean

countryAustralia & New Zealand

countryChina

countryJapan En Jp

countryKorea

countryTaiwan

India & Middle East

country IndiaIndia

countryMiddle East

Africa

countryGlobal Site

< Pharmaceutical & Life Sciences

IDC Spotlight: Digital and Clinical Biomarkers

comments.png fav-article share icon
comments.png liked.png

IDC Spotlight: Digital and Clinical Biomarkers

As digital health technologies accumulate more and more patient data, stakeholders across the healthcare value chain are looking to digital biomarkers as crucial counterparts to clinical biomarker data

In a recent IDC Spotlight report, Dr. Nimita Limaye explores how digital biomarkers are changing the life sciences and healthcare landscape, driving improvements in clinical trial patient recruitment, clinical trial design and predictive/preventative care.

“The ability to combine insights from both digital and clinical biomarkers, and to obtain a holistic understanding of a patient’s health, holds enormous promise,” observes Dr. Limaye. She notes that the digital biomarker market has seen double digit growth, in part because digital biomarkers deliver noninvasive, passive, continuous measurement, and are a key enabler of remote and decentralized clinical trials.

Dr. Limaye emphasizes the role of robust biomarker hubs in driving digital innovation: “A biomarker hub that can integrate these diverse types of biomarker data and tap into phenotypic and digital real-world data (RWD) provides powerful synergies to drive clinical trial strategy, inform clinical trial design, and drive portfolio management decisions.”

Dr. Limaye points to AI/ML and cloud computing, in particular, as technologies that will enable hyperscalers to transform massive amounts of data into meaningful intelligence that drives treatment decisions.

IDC Spotlight: Digital and Clinical Biomarkers

Download Report
© 2023 Wipro
Disclaimer Privacy
X

Share Icon
popup-image

Contact Wipro

Please fill the required details to access the content

loading.gif